ArticleOncotarget2014

Engineered ubiquitin ligase PTB-U-box targets insulin/insulin-like growth factor receptor for degradation and coordinately inhibits cancer malignancy.

Qinhao Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.